Log In
BCIQ
Print this Print this
 

CB7993113

  Manage Alerts
Collapse Summary General Information
Company Hercules Pharmaceuticals B.V.
DescriptionSmall molecule inhibitor of aryl hydrocarbon receptor (AHR)
Molecular Target Aryl hydrocarbon receptor (AHR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat triple-negative breast cancer (TNBC)
Regulatory Designation
PartnerBoston University

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today